- Home
- SVV vs AGIO Comparison
SVV vs AGIO Comparison
Compare SVV & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVV
- AGIO
- Stock Information
- Founded
- SVV 1954
- AGIO 2007
- Country
- SVV United States
- AGIO United States
- Employees
- SVV N/A
- AGIO N/A
- Industry
- SVV Other Specialty Stores
- AGIO Biotechnology: Pharmaceutical Preparations
- Sector
- SVV Consumer Discretionary
- AGIO Health Care
- Exchange
- SVV Nasdaq
- AGIO Nasdaq
- Market Cap
- SVV 2.0B
- AGIO 2.4B
- IPO Year
- SVV 2023
- AGIO 2013
- Fundamental
- Price
- SVV $13.63
- AGIO $43.98
- Analyst Decision
- SVV Buy
- AGIO Strong Buy
- Analyst Count
- SVV 7
- AGIO 4
- Target Price
- SVV $13.17
- AGIO $59.33
- AVG Volume (30 Days)
- SVV 1.2M
- AGIO 519.0K
- Earning Date
- SVV 10-30-2025
- AGIO 10-30-2025
- Dividend Yield
- SVV N/A
- AGIO N/A
- EPS Growth
- SVV N/A
- AGIO N/A
- EPS
- SVV 0.20
- AGIO 11.13
- Revenue
- SVV $1,584,135,000.00
- AGIO $40,875,000.00
- Revenue This Year
- SVV $10.11
- AGIO $23.74
- Revenue Next Year
- SVV $7.09
- AGIO $159.90
- P/E Ratio
- SVV $67.27
- AGIO $3.89
- Revenue Growth
- SVV 4.47
- AGIO 30.57
- 52 Week Low
- SVV $6.48
- AGIO $23.42
- 52 Week High
- SVV $13.89
- AGIO $62.58
- Technical
- Relative Strength Index (RSI)
- SVV 61.11
- AGIO 65.99
- Support Level
- SVV $12.28
- AGIO $41.24
- Resistance Level
- SVV $13.64
- AGIO $43.67
- Average True Range (ATR)
- SVV 0.47
- AGIO 1.47
- MACD
- SVV 0.03
- AGIO 0.11
- Stochastic Oscillator
- SVV 85.40
- AGIO 100.00
About SVV Savers Value Village Inc.
Savers Value Village Inc is a for-profit thrift operator in the United States and Canada. It purchases second hand textiles (i.e., clothing, bedding, and bath items), shoes, accessories, housewares, books, and other goods from its non-profit partners (NPPs), either directly from them or via on-site donations (OSDs) at Community Donation Centers at its stores. The company then processes, selects, prices, merchandise, and sells these items in its stores.
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.